Patient Information
Name
NA
Assay ordered
NA
Gender
NA
Sample type
NA
DOB
NA
Collection Date
NA
Patient ID
NA
Report Date
NA
List of all provided patient medications:
Ibuprofen
Zoloft
Atorvastatin
Codeine
Section I: Genotype Summary
| Gene | Genotype | Phenotype |
|---|---|---|
| ABCG2 | Normal for rs2231142 | Normal Metabolizer |
| CACNA1S | Normal for rs772226819 & rs1800559 | Uncertain Susceptibility |
| CFTR | Normal function | Ivacaftor non-responsive in CF patients |
| CYP2B6 | *1/*1 | Normal Metabolizer |
| CYP2C19 | *38/*38 | Normal Metabolizer |
| CYP2C9 | *1/*1 | Normal Metabolizer |
| CYP3A4 | *1/*22 | Indeterminate Metabolizer |
| CYP3A5 | *3/*3 | Poor Metabolizer |
| CYP4F2 | *1/*1 | Normal Metabolizer |
| DPYD | c.496A>G (heterozygous) | Normal Metabolizer |
| G6PD | Normal function | Normal Metabolizer |
| NUDT15 | *1/*1 | Normal Metabolizer |
| RYR1 | Normal function | Uncertain Susceptibility |
| SLCO1B1 | *15/*37 | Decreased Function |
| TPMT | *1/*1 | Normal Metabolizer |
| UGT1A | *1/*1 | Normal Metabolizer |
| VKORC1 | Normal for rs9923231 | Normal Metabolizer |
| CYP2D6 | *1/*1 | Normal Metabolizer |
| Prothrombin (F2) | Normal for G20210A | Normal |
| Factor V Leiden | Heterozygous for G1691A | Increased Risk of Thrombosis |
| MTHFR | Heterozygous for C677T & A1298C | No Increased Risk of Hyperhomocysteinemia |
| BRAF (V600E) | c.1799T>A | Normal |
| KRAS | Codon12/13 | Normal |
| NRAS | Codon12/13 | Normal |
| HTR2A | rs7997012, rs3813929 | Normal |
| COMT | rs4680 (Val158Met) | Normal Function |
| GRIK4 | rs1954787 | Normal |
| OPRM1 | rs1799971 | Normal Function |
| ITGB3 | rs5918 | Normal Function |